Abstract: The Feasibility and Efficacy of a Mental and Sexual Health Intervention for Chinese-, Korean-, Vietnamese American Women: A Randomized Clinical Trial (Society for Social Work and Research 22nd Annual Conference - Achieving Equal Opportunity, Equity, and Justice)

703P The Feasibility and Efficacy of a Mental and Sexual Health Intervention for Chinese-, Korean-, Vietnamese American Women: A Randomized Clinical Trial

Schedule:
Sunday, January 14, 2018
Marquis BR Salon 6 (ML 2) (Marriott Marquis Washington DC)
* noted as presenting author
Hyeouk Hahm, PhD, Associate Professor, Boston University School of Social Work, Boston, MA
Lina Zhou, MS, Student, Boston University, Boston, MA
Mihoko Maru, MSW, Doctoral Student, Boston University, Boston, MA
Nishtha Ahuja, Student, Boston University, Boston, MA
Eric Kolaczyk, PhD, Professor, Boston University, Boston, MA
Background: To our knowledge, Asian Women’s Action for Resilience and Empowerment (AWARE) is the first gender and culture specific intervention designed for Chinese-, Korean-, and Vietnamese-American young women with histories of interpersonal trauma. 

Objectives: To test whether AWARE reduced depressive symptoms and sexual risk behaviors in participants over time. We also tested whether treatment effects would differ by the presence of a PTSD diagnosis at baseline. 

Research Design: We employed a two-arm randomized clinical trial.  Of 435 women who were initially screened, 63 women were eligible and randomized into either the intervention (n=32) or waitlist control (n=31) group (14.3% inclusion rate).  AWARE consisted of 8 group sessions. 

Measures: Retention rates, depressive symptoms, and sexual risk behaviors were assessed at baseline, post-intervention, and 3-month follow-up.  The PCL-C (PTSD Checklist, Civilian version) was used to diagnose PTSD at baseline. 

Results: 87.5% of randomized participants who started AWARE completed at least 6 of the 8 sessions.  Compared to the control group, the intervention group did not experience reductions in depressive symptoms or sexual risk behaviors over time after controlling for baseline depressive symptoms.  However, women with PTSD at baseline experienced significant reductions in depressive symptoms with an effect size of 0.84.  

Conclusions: While AWARE did not demonstrate an overall effect on depressive symptoms or sexual risk behaviors, it is a highly feasible intervention that is efficacious in reducing depressive symptoms over time for those with PTSD.  A full RCT is needed for future studies.